The DOI matches its Crossref record; 145 of the 145 references it cites were found in a registry or an index.
Type 2 diabetes mellitus, cognitive impairment and dementia
Abstract
Summary: Aims We set out to examine the evidence for an association between cognitive impairment or dementia and the presence of Type 2 diabetes mellitus (DM). We also sought evidence of potential mechanisms for such an association. Methods A literature search of three databases was performed and the reference lists of the papers so identified were examined, using English language papers only. Results We found evidence of cross‐sectional and prospective associations between Type 2 DM and cognitive impairment, probably both for memory and executive function. There is also evidence for an elevated risk of both vascular dementia and Alzheimer’s disease in Type 2 DM albeit with strong interaction of other factors such as hypertension, dyslipidaemia and apolipoprotein E phenotype. Both vascular and non‐vascular factors are likely to play a role in dementia in diabetes. Conclusions Current classification structures for dementia may not be adequate in diabetes, where mixed pathogenesis is likely. Further research into the mechanisms of cognitive impairment in Type 2 DM may allow us to challenge the concept of dementia, at least in these patients, as an irremediable disease. Diabet. Med. 16, 93–112 (1999)
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“There is a growing literature indicating that individuals with diabetes have impairments in recent memory (3–6).”
From Reduced glucose tolerance is associated with poor memory performance and hippocampal atrophy among normal elderly (2003) · cites this paper as [4]
In the citing paper
“However, many of these studies were cross-sectional and were thus unable to provide estimates of diabetes as a risk factor for future cognitive dysfunction.”
From Cognitive decline and dementia in diabetes—systematic overview of prospective observational studies (2005) · cites this paper as [6]
In the citing paper
“Recent evidence from several epidemiological studies suggests that it is also a risk factor for cognitive dysfunction [3 -6].”
From Cognitive decline and dementia in diabetes—systematic overview of prospective observational studies (2005) · cites this paper as [6]
In the citing paper
“Indeed, only one [7] of the review articles that summarised the available data pertaining to this relationship [4, 6 -11] provided a quantitative estimate.”
From Cognitive decline and dementia in diabetes—systematic overview of prospective observational studies (2005) · cites this paper as [6]
In the citing paper
“These findings are supported by previous reviews of the available longitudinal studies [3, 4, 6].”
From Cognitive decline and dementia in diabetes—systematic overview of prospective observational studies (2005) · cites this paper as [6]
Citations
Cites
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915
Diagnostic and Statistical Manual of Mental Disorders
&NA; (1988) · Alzheimer Disease & Associated Disorders · doi:10.1097/00002093-198802020-00022 · Cited by 12,603
Role of Insulin Resistance in Human Disease
Reaven, G. M. (1988) · Diabetes · doi:10.2337/diab.37.12.1595 · Cited by 12,154
Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B
Cross, D. A. E., Alessi, D. R., Cohen, P., Andjelkovich, M., & Hemmings, B. A. (1995) · Nature · doi:10.1038/378785a0 · Cited by 5,244
Alzheimer's Disease: A Disorder of Cortical Cholinergic Innervation
Coyle, J. T., Price, D. L., & DeLong, M. R. (1983) · Science · doi:10.1126/science.6338589 · Cited by 3,052
RAGE and amyloid-β peptide neurotoxicity in Alzheimer's disease
Yan, S. D., Chen, X., Fu, J., Chen, M., Zhu, H., Roher, A., Slattery, T., Zhao, L., Nagashima, M., Morser, J., et al. (1996) · Nature · doi:10.1038/382685a0 · Cited by 2,012
Brain Infarction and the Clinical Expression of Alzheimer Disease<subtitle>The Nun Study</subtitle>
Snowdon, D. A. (1997) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1997.03540340047031 · Cited by 1,590
Cooper, G. J., Willis, A. C., Clark, A., Turner, R. C., Sim, R. B., & Reid, K. B. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.23.8628 · Cited by 1,299
Bucala, R., Tracey, K. J., & Cerami, A. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115014 · Cited by 1,162
Harris, M. I., Hadden, W. C., Knowler, W. C., & Bennett, P. H. (1987) · Diabetes · doi:10.2337/diab.36.4.523 · Cited by 1,096
Research works printed but not linked: 8
- Jagusch W, 1992, Cognitive function and metabolic state in elderly diabetic patients., Diab Nutr Metab., 5, 265
- Breteler MmB.Cognitive Decline in the Elderly.Published Thesis ISBN 90–90006241–6.1993.
- Amato L, 1996, Non‐insulin‐dependent diabetes mellitus is associated with a greater prevalence of depression in the elderly., Diabetes Metab., 22, 314
- Kokeman E, 1960, Dementia after ischemic stroke: a population‐based study in Rochester., Minnesota. Neurology 1996, 19, 154
- Ott A, 1997, Risk of Dementia.
- Chew W, 1991, Hyperglycemia augments ischemic brain injury., Am J Neuroradiol., 12, 603
- 10.1210/en.138.5.1886 · DOI
- 10.1210/jc.81.4.1657 · DOI
Cited by
Sorted by citations
Items 201–300 of 563
Short-term longitudinal trends in cognitive performance in older adults with type 2 diabetes
Fischer, A. L., de Frias, C. M., Yeung, S. E., & Dixon, R. A. (2009) · Journal of Clinical and Experimental Neuropsychology · doi:10.1080/13803390802537636 · Cited by 51
“Findings on the broad and multidimensional construct of executive function are similarly mixed in the diabetes literature and are likely related to the fact that single tests may represent different aspects of the domain for both healthy and special populations of older adults ( Awad et al, 2004 ; de Frias, Dixon, & S…”
Asimakopoulou, K. G., Hampson, S. E., & Morrish, N. J. (2002) · Diabetic Medicine · doi:10.1046/j.1464-5491.2002.00680.x · Cited by 50
Zhao, C., Liu, H.-Q., Cao, R., Ji, A.-L., Zhang, L., Wang, F., & Yang, R. (2012) · Brain Research · doi:10.1016/j.brainres.2012.03.067 · Cited by 50
Molecular and biochemical trajectories from diabetes to Alzheimer’s disease: A critical appraisal
Sandhir, R., & Gupta, S. N. (2015) · World Journal of Diabetes · doi:10.4239/wjd.v6.i12.1223 · Cited by 49
Meng, L., Li, X., Shen, L., & Ji, H. (2020) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2020.02.002 · Cited by 49
de Moraes, S. A., Szklo, M., Knopman, D. S., & Sato, R. (2002) · Preventive Medicine · doi:10.1006/pmed.2002.1077 · Cited by 49
Vascular risk factors and cognitive decline among elderly male twins
Xiong, G. L., Plassman, B. L., Helms, M. J., & Steffens, D. C. (2006) · Neurology · doi:10.1212/01.wnl.0000242730.44003.1d · Cited by 49
Christman, A. L., Vannorsdall, T. D., Pearlson, G. D., Hill‐Briggs, F., & Schretlen, D. J. (2009) · Archives of Clinical Neuropsychology · doi:10.1093/arclin/acp091 · Cited by 48
“The two existing major published reviews of cognition studies in diabetes (Stewart & Liolitsa, 1999; Strachan, Dreary, Ewing, & Frier, 1997a) * Corresponding author at: Welch Center for Prevention, Epidemiology, and Clinical Research, 2024 E. Monument Street, Suite 2-600, Baltimore, MD 21287, USA.”
BackgroundHuang, R., Jia, B., Xie, L., Ma, S., Yin, J., Sun, Z., Le, H., Xu, W., Huang, J., & Luo, D.-X. (2015) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.24967 · Cited by 49
“Some neuropsychological studies have reported that DM patients have mild cognitive impairment (MCI), particularly for tasks involving verbal memory or complex information processing.(5,6) Ruis et al 7 found that MCI was already present in the early stages of T2DM patients, and Dey et al 8 reported cognitive impairment…”
BackgroundCognitive functioning and structural brain abnormalities in people with Type 2 diabetes mellitus
Mankovsky, B., Zherdova, N., van den Berg, E., Biessels, G. J., & de Bresser, J. (2018) · Diabetic Medicine · doi:10.1111/dme.13800 · Cited by 48
van der Graaf, M., Janssen, S. W. J., van Asten, J. J. A., Hermus, A. R., Sweep, F. C. G. J., Pikkemaat, J. A., Martens, G. J. M., & Heerschap, A. (2004) · NMR in Biomedicine · doi:10.1002/nbm.896 · Cited by 48
“especially in older type 2 diabetic patients, cognitive deficits can be observed.(5) In diabetic rats, central nervous system damage is characterized by impairment of learning and memory, changes in synaptic plasticity and neurophysiologic alterations.”
BackgroundUmegaki, H., Iimuro, S., Shinozaki, T., Araki, A., Sakurai, T., Iijima, K., Ohashi, Y., Ito, H., & the Japanese Elderly Diabetes Intervention Trial Study Group (2012) · Geriatrics and gerontology international/Geriatrics & gerontology international · doi:10.1111/j.1447-0594.2011.00817.x · Cited by 50
Nasri, S., Roghani, M., Baluchnejadmojarad, T., Balvardi, M., & Rabani, T. (2012) · Phytotherapy Research · doi:10.1002/ptr.3702 · Cited by 47
“…pathogenesis of cognitive and memory impairments in diabetes is not completely understood, several factors such as metabolic impairments, vascular complications and enhanced release of free radicals have been implicated (Stewart and Liolitsa, 1999; Biessels et al., 2007; Kucukatay et al., 2007).”
BackgroundLipidomic Profiles in Diabetes and Dementia
Huynh, K., Martins, R. N., & Meikle, P. J. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-161215 · Cited by 47
“It is now established that T2D is associated with poorer cognitive outcomes, especially in the elderly [12], and in the past decade, mounting evidence suggests T2D as a strong risk factor for dementia and AD [13].”
Cognitive function and risk of stroke in elderly men
Wiberg, B., Lind, L., Kilander, L., Zethelius, B., Sundelöf, J. E., & Sundström, J. (2010) · Neurology · doi:10.1212/wnl.0b013e3181ccc516 · Cited by 46
Kamiyama, K., Wada, A., SUGIHARA, M., Kurioka, S., Hayashi, K., Hayashi, T., Yoshisako, T., Yamamoto, N., Tsuchie, Y., Yamaguchi, S., et al. (2010) · Japanese Journal of Radiology · doi:10.1007/s11604-009-0416-2 · Cited by 46
Cerebrospinal fluid levels of insulin in patients with Alzheimer's disease
Pérez-Molina, J. A., Jiménez-Jiménez, F. J., Vargas, C., Gómez, P. A., de Bustos, F., Gómez-Escalonilla, C., Zurdo, M., Tallón-Barranco, A., Martínez‐Salio, A., Porta-Etessam, J., et al. (2002) · Acta Neurologica Scandinavica · doi:10.1034/j.1600-0404.2002.01326.x · Cited by 46
Longitudinal evaluation of memory performance and peripheral neuropathy in the Ins2C96Y Akita mice
Choeiri, C., Hewitt, K. E., Durkin, J. P., Simard, C. J., Renaud, J., & Messier, C. (2004) · Behavioural Brain Research · doi:10.1016/j.bbr.2004.06.005 · Cited by 48
Hewer, W., Mussell, M., Rist, F., Kulzer, B., & Bergis, K. (2003) · Gerontology · doi:10.1159/000067947 · Cited by 47
Age, vascular risk, and cognitive decline in an older, British, African-Caribbean population.
Stewart, R., Prince, M., & Mann, A. (2003) · Journal of the American Geriatrics Society · doi:10.1046/j.1532-5415.2003.51504.x · Cited by 45
“Diabetes mellitus may modify the association between age and cognitive decline through several mechanisms, including levels of cerebrovascular disease, cerebral effects of hyper- or hypoglycemia, and potentially common pathways underlying insulin resistance and neurodegeneration.(37) Causal pathways are of relevance f…”
BackgroundMethylglyoxal can mediate behavioral and neurochemical alterations in rat brain
Hansen, F., Pandolfo, P., Galland, F., Torres, F. V., Dutra, M. F., Batassini, C., Guerra, M. C., Leite, M. C., & Gonçalves, C. (2016) · Physiology & Behavior · doi:10.1016/j.physbeh.2016.05.046 · Cited by 45
Umegaki, H., Iimuro, S., Shinozaki, T., Araki, A., Sakurai, T., Iijima, K., Ohashi, Y., Ito, H., & the Japanese Elderly Diabetes Intervention Trial Study Group (2012) · Geriatrics and gerontology international/Geriatrics & gerontology international · doi:10.1111/j.1447-0594.2011.00818.x · Cited by 45
Liolitsa, D. (2002) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.73.3.261 · Cited by 45
Self-citationThe Association Between Light Physical Activity and Cognition Among Adults: A Scoping Review
Erlenbach, E. D., McAuley, E., & Gothe, N. P. (2021) · The Journals of Gerontology Series A · doi:10.1093/gerona/glab013 · Cited by 51
Excessive daytime sleepiness in migraine patients
Peres, M. F. P. (2005) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2005.062497 · Cited by 43
Biessels, G. J., Smale, S., Duis, S., Kamal, A., & Gispen, W. H. (2001) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(00)00456-1 · Cited by 43
Cardiovascular Risk Factors Cause Cortical Thinning in Cognitively Impaired Patients
Seo, S. W., Lee, J., Im, K., Park, J.-S., Kim, S.-H., Kim, S. T., Ahn, J., Kim, M.-J., Kim, G. H., Kim, J., et al. (2011) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0b013e31822e0831 · Cited by 42
“Our findings may be in line with previous neuropsychological results showing that DM correlated with cognitive impairments in attention, executive functioning, and/or information processing.(29,30) The lack of association between hyperlipidemia and cortical thinning is notable, because hyperlipidemia is an important r…”
ResultThe etiology of age-related dementia is more complicated than we think
McDonald, R. J., Craig, L. A., & Hong, N. S. (2010) · Behavioural Brain Research · doi:10.1016/j.bbr.2010.05.005 · Cited by 42
Karter, A. J., Laiteerapong, N., Chin, M. H., Moffet, H. H., Parker, M. M., Sudore, R. L., Adams, A. S., Schillinger, D., Adler, N., Whitmer, R. A., et al. (2015) · Journal of Aging and Health · doi:10.1177/0898264315569455 · Cited by 49
“However, the basic epidemiology of geriatric conditions, particularly with respect to ethnic differences, has not been well studied in older patients with diabetes (Anderson et al., 2001; Bertoni, Krop, Anderson, & Brancati, 2002; J. S. Brown, et al., 1996; Stewart & Liolitsa, 1999).”
BackgroundKinase–Kinase Interaction and Modulation of Tau Phosphorylation
Hashiguchi, M., & Hashiguchi, T. (2012) · International review of cytology · doi:10.1016/b978-0-12-405210-9.00004-7 · Cited by 44
Central nervous system involvement in diabetes mellitus
Selvarajah, D., & Tesfaye, S. H. (2006) · Current Diabetes Reports · doi:10.1007/s11892-006-0075-y · Cited by 42
“Epidemiologic studies have reported that diabetes is an independent risk factor for cognitive impairment [3, 4 ].”
BackgroundInfluentialvan den Berg, E. (2005) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2005.062737 · Cited by 42
Lovestone, S. (1999) · Neurology · doi:10.1212/wnl.53.9.1907 · Cited by 42
Editorial: Diabetes Mellitus: A Major Disease Of Older Persons
Morley, J. E. (2000) · The Journals of Gerontology Series A · doi:10.1093/gerona/55.5.m255 · Cited by 42
Wayhs, C. A. Y., Manfredini, V., Sitta, Â., Deon, M., Ribas, G. S., Vanzin, C. S., Biancini, G. B., Ferri, M. K., Nin, M. S., Barros, H. M. T., et al. (2010) · Metabolic Brain Disease · doi:10.1007/s11011-010-9211-0 · Cited by 41
“Since the early 20th century the cognitive dysfunction of diabetic subjects has been recognized (Miles and Root 1922) and several studies of diabetic subjects have described neuropsychological and neurobehavioral changes (Strachan et al. 1997; Stewart and Liolitsa 1999), suggesting that diabetic encephalopathy could b…”
BackgroundSharifzadeh, M. S., Ranjbar, A., Hosseini, A., & Khanavi, M. (2017) · PubMed Central · Cited by 41
Corraliza-Gómez, M., Bermejo, T., Lilue, J., Rodríguez-Iglesias, N., Valero, J., Cózar‐Castellano, I., Arranz, E. M., Sánchez, D., & Ganfornina, M. D. (2023) · Journal of Neuroinflammation · doi:10.1186/s12974-023-02914-7 · Cited by 39
“…cross-sectional studies in humans show such association in a bidirectional manner: T2D is over-represented in AD patients in comparison with controls [15–17] and, on the other hand, large population-based longitudinal studies show that T2D may significantly increase the risk of AD [18–21].”
ResultNeurocognitive impairment and comorbid depression in patients of diabetes mellitus
Solanki, R. K., Dubey, V., & Munshi, D. (2009) · International Journal of Diabetes in Developing Countries · doi:10.4103/0973-3930.54291 · Cited by 40
“The speciÞ c mechanism linking type 2 diabetes with cognitive deÞ cits has not been identiÞ ed; however, extraneuronal hyperglycemia, disturbed brain glucose metabolism, altered brain insulin signaling[8] and complications secondary to potential hypercortisolemia have all been implicated.”
Effect of age and glucoregulation on cognitive performance
Messier, C., Tsiakas, M., Gagnon, M., & Desrochers, A. (2010) · Journal of Clinical and Experimental Neuropsychology · doi:10.1080/13803390903540323 · Cited by 39
“…& De Leon, 2003; Kaplan et al., 2000), adults with impaired glucose tolerance (Vanhanen et al., 1997; Vanhanen et al., 1998), and in older adults with type 2 diabetes (Awad et al., 2004; Biessels et al., 2002; Stewart & Liolitsa, 1999; Strachan et al., 1997; Strachan, Frier, & Deary, 2003).”
Tang, X., Brinton, R. D., Chen, Z., Farland, L. V., Klimentidis, Y. C., Migrino, R. Q., Reaven, P. D., Rodgers, K. E., & Zhou, J. J. (2022) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2022-002894 · Cited by 38
The prevalence and predictors of cognitive impairment in type 2 diabetic population of Punjab, India
Khullar, S., Kaur, G., Dhillon, H., Sharma, R., Mehta, K., Singh, M., & Singh, P. (2016) · Journal of Social Health and Diabetes · doi:10.4103/2321-0656.193996 · Cited by 39
“However, conclusions vary depending on the sampling strategy, study design, tests for cognition used, diabetes severity, and co-existing morbidities.([6,7]) Several association pathways of T2DM and cognitive decline have been established whereby some studies reported the association of diabetes with Alzheimer’s([8]) a…”
BackgroundThielen, J.-W., Gancheva, S., Hong, D., Rankouhi, S. R., Chen, B., Apostolopoulou, M., Anadol, E., Roden, M., Norris, D. G., & Tendolkar, I. (2019) · Human Brain Mapping · doi:10.1002/hbm.24702 · Cited by 37
“In this regard, previous work has mainly investigated T2D related decline in single item memory, for example, word list learning (Jones et al., 2014; Stewart & Liolitsa, 1999), which is a different process with distinct neural substrates as compared to associative memory (Ranganath, 2010; Wang, Li,…”
BackgroundAccuracy of Self-Monitored Blood Glucose in Type 2 Diabetes
Kazlauskaite, R., Soni, S., Evans, A. T., Graham, K., & Fisher, B. (2009) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2008.0111 · Cited by 39
“…of glucose self-monitoring might be adversely affected not only by the common conditions of depression and low literacy, but also by cognitive impaired from ‘‘diabetic encephalopathy,’’ 16 which was recently correlated with lesions on brain imaging by the Utrecht Diabetic Encephalopathy Group.”
Biessels, G. J., Braun, K. P. J., de Graaf, R. A., van Eijsden, P., Gispen, W. H., & Nicolay, K. (2001) · Diabetologia · doi:10.1007/s001250051625 · Cited by 37
Tiehuis, A. M., van der Meer, F. S., Mali, W. P. T. M., Pleizier, M., Biessels, G. J., Kappelle, J. L. J., & Luijten, P. R. (2009) · Neuroradiology · doi:10.1007/s00234-009-0598-4 · Cited by 37
“An important complication of DM2 is an increased risk for dementia [1].”
BackgroundPostural control and detection of slip/fall initiation in the elderly population
Kim, B., & Robinson, C. J. (2005) · Ergonomics · doi:10.1080/00140130500071028 · Cited by 36
“1991 , Stewart and Liolits 1999 , Gispen and Biessels 2000 ) have reported that diabetic people showed slower cognition, lack of proprioceptive feedback and higher magnitude of sway compared to the age-matched non-diabetic group.”
Association between Toxoplasma gondii seropositivity and memory function in nondemented older adults
Wyman, C. E., Gale, S. D., Hedges‐Muncy, A., Erickson, L. D., Wilson, E., & Hedges, D. W. (2017) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2017.01.018 · Cited by 36
“Introduction Multiple factors are associated with cognitive function and cognitive aging in older adults including sociodemographic variables, lifestyle, and diseases such as hypertension and diabetes (Gifford, et al., 2013, Stewart and Liolitsa, 1999, Zhang, et al., 2015).”
BackgroundResultInfluentialŞahin, K., Tuzcu, M., Orhan, C., Ağca, C. A., Şahin, N., Güvenç, M., Krejpcio, Z., Staniek, H., & Hayırlı, A. (2010) · Biological Trace Element Research · doi:10.1007/s12011-010-8905-9 · Cited by 36
“There are cross-sectional and prospective associations between type 2 diabetes and cognitive impairment, probably both for memory and executive functions [48, 49].”
BackgroundManschot, S., Gispen, W. H., Kappelle, L. J., & Biessels, G. J. (2003) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.401 · Cited by 36
“Furthermore, recent epidemiological studies demonstrate an association between diabetes and vascular dementia as well as Alzheimer’s disease [3,5].”
BackgroundThe Synergistic Effects of HIV, Diabetes, and Aging on Cognition
Vance, D. E., Fazeli, P. L., Dodson, J. E., Ackerman, M. L., Talley, M. H., & Appel, S. J. (2014) · Journal of Neuroscience Nursing · doi:10.1097/jnn.0000000000000074 · Cited by 36
“…of patients with type 2 diabetes when compared with the general population across all age groups (Noble, Manly, Schupf, Tang, & Luchsinger, 2012; Stewart & Liolitsa, 1999; Strachan, Deary, Ewing, & Frier, 1997), whereas longitudinal studies suggest a slow process of developing cognitive…”
BackgroundCerebrovascular degradation of TRKB by MMP9 in the diabetic brain
Navaratna, D., Fan, X., Leung, W., Lok, J., Guo, S., Xing, C., Wang, X., & Lo, E. H. (2013) · Journal of Clinical Investigation · doi:10.1172/jci65767 · Cited by 32
Riby, L. M., Marriott, A., Bullock, R. M., Hancock, J., Smallwood, J., & McLaughlin, J. (2008) · European Journal of Clinical Nutrition · doi:10.1038/sj.ejcn.1602981 · Cited by 34
“Even with limited knowledge of how these factors interact, an elevated risk of both vascular dementia and AD exists for those with diabetes and associated disorders (Stewart and Liolitsa, 1999; Messier, 2005).”
BackgroundFulk, G. D., Robinson, C. J., Mondal, S., Storey, C. M., & Hollister, A. M. (2010) · Journal of NeuroEngineering and Rehabilitation · doi:10.1186/1743-0003-7-44 · Cited by 34
“Since our method of assessing psychophysical thresholds of balance requires attention, mild cognitive impairments secondary to diabetes could be involved [ 36 ,37].”
MethodZhou, Y., Luo, Y., & Dai, J. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-121762 · Cited by 33
“lesions, and cortical and subcortical atrophy [10–13].”
Caffeine, Diabetes, Cognition, and Dementia
Biessels, G. J. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-091228 · Cited by 34
“5) in populations with a mean age below 60 [28, 31].”
Komorowski, J. R., Tuzcu, M., Şahin, N., Juturu, V., Orhan, C., Ulaş, M., & Şahin, K. (2012) · Biological Trace Element Research · doi:10.1007/s12011-012-9393-x · Cited by 32
“Stewart and Liolitsa [33] concluded that there is a cross-sectional and prospective association between type 2 and cognitive impairment, probably both for memory and executive functions.”
BackgroundGlucose tolerance and cognitive impairment in an elderly population
La, H., Keinanen-Kiukaanniemi, S. M., & Läärä, E. (2001) · Public Health · doi:10.1038/sj.ph.1900758 · Cited by 32
Kamal, A., Artola, A., Biessels, G. J., Gispen, W. H., & Ramakers, G. M. J. (2003) · Neuroscience · doi:10.1016/s0306-4522(02)00874-6 · Cited by 32
A comparative study of reaction times between type II diabetics and non-diabetics
Richerson, S. J., Robinson, C. J., & Shum, J. (2005) · BioMedical Engineering OnLine · doi:10.1186/1475-925x-4-12 · Cited by 32
“In addition to the measured effects in these two studies, diabetes has also been shown to affect peripheral nerves in the somatosensory [7] and auditory system [8], slows psychomotor responses [9], and has cognitive effects on those individuals without proper metabolic control [ 10- 13 ], all of which may affect react…”
BackgroundBrain insulin resistance and Alzheimer’s disease: a systematic review
Andrade, L. J. D. O., de Oliveira, L. M., Bittencourt, A. M. V., Lourenço, L. G. D. C., & de Oliveira, G. C. M. (2024) · Dementia & Neuropsychologia · doi:10.1590/1980-5764-dn-2023-0032 · Cited by 35
“These studies reported that higher hemoglobin A1c levels were associated with more severe deficiencies, including memory impairments 53 .”
BackgroundKim, E., Lee, S. H., Lee, K. S., Cheong, H., Namkoong, K., Hong, C. H., & Oh, B. H. (2011) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2011.07.005 · Cited by 31
The Brain-Gut-Islet Connection
Woods, S. C., Benoit, S. C., & Clegg, D. J. (2006) · Diabetes · doi:10.2337/db06-s015 · Cited by 30
Palomo‐Osuna, J., Sola, H. D., Dueñas, M., Moral-Muñoz, J. A., & Failde, I. (2022) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2022.2048649 · Cited by 31
“tive impairment and dementia [48,49] and that fluctuations in blood sugar levels, insulin resistance and deposits of β-”
BackgroundBrayne, C., Gao, L., & Matthews, F. E. (2005) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.09.030 · Cited by 30
Bali, P., Kaur, N., Tiwari, A., Bammidi, S., Podder, V., Devi, C., Kumar, S., Sivapuram, M. S., Ghani, A., Modgil, S., et al. (2020) · Neuroepidemiology · doi:10.1159/000505816 · Cited by 32
Cognitive neuropsychology of Alzheimer's disease
Crutch, S. J. (2005) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2005.063982 · Cited by 30
The Additive Effects of Type-2 Diabetes on Cognitive Function in Older Adults with Heart Failure
Alosco, M. L., Spitznagel, M. B., van Dulmen, M. H. M., Raz, N., Cohen, R. A., Sweet, L. H., Colbert, L. H., Josephson, R., Hughes, J. W., Rosneck, J., et al. (2012) · Cardiology Research and Practice · doi:10.1155/2012/348054 · Cited by 29
“It is likely that T2DM could be an important contributor to cognitive dysfunction in HF, as patients with T2DM are at increased risk for cognitive impairment independent of HF [18, 19].”
BackgroundGait Parameters and Peripheral Neuropathy in Patients With Diabetes: A Meta-Analysis
Wang, Z., Peng, S., Zhang, H., Sun, H., & Hu, J. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.891356 · Cited by 32
“Epidemiologic studies have reported that diabetes is an independent risk factor for cognitive impairment (34, 35).”
BackgroundWhich aspects of executive dysfunction influence ability to manage diabetes in older adults?
Munshi, M. N., Hayes, M., Iwata, I., Lee, Y., & Weinger, K. (2012) · Diabetic Medicine · doi:10.1111/j.1464-5491.2012.03606.x · Cited by 31
McFall, G. P., Geall, B. P., Fischer, A. L., Dolcos, S. M., & Dixon, R. A. (2010) · Neuropsychology · doi:10.1037/a0019246 · Cited by 32
“When presenting with T2D, obesity (often measured as BMI) could affect cognitive performance through a variety of peripheral processes (e.g., sleep disturbance and apnoeic episodes; see McEwen, 2006; Stewart & Liolitsa, 1999).”
BackgroundInfluentialGlycemic load and risk of Alzheimer's disease.
Luchsinger, J. A., Tang, M. ‐., & Mayeux, R. P. (2007) · PubMed · Cited by 29
Diabetes mellitus and cognitive performance in older women
Crooks, V. C., Buckwalter, J. G., & Petitti, D. B. (2003) · Annals of Epidemiology · doi:10.1016/s1047-2797(03)00059-0 · Cited by 28
Biessels, G. J., ter Laak-Poort, M., Kamal, A., & Gispen, W. H. (2005) · Brain Research · doi:10.1016/j.brainres.2004.12.025 · Cited by 29
Jamali, A., Shahrbanian, S., & Tayebi, S. M. (2020) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-020-00529-w · Cited by 30
Factors Associated with Cognitive Decline in Elderly Diabetics
Umegaki, H., Kawamura, T., Kawano, N., Umemura, T., Kanai, A., & Sano, T. (2011) · Dementia and Geriatric Cognitive Disorders Extra · doi:10.1159/000323188 · Cited by 28
Utkan, T., Yazır, Y., Karson, A., & Bayramgürler, D. (2015) · Current Neurovascular Research · doi:10.2174/1567202612666150311111340 · Cited by 27
“Second, DM is associated with moderate cognitive function impairments, and patients carry a high risk of dementia [44, 4, 1].”
BackgroundNeuro-Psychiatric Alterations in Patients with Diabetic Foot Syndrome
Navarro‐Flores, E., Pérez‐Ros, P., Martínez‐Arnau, F. M., Julían-Rochina, I., & Cauli, O. (2019) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527318666191002094406 · Cited by 28
Mild Cognitive Impairment and Donepezil Impact Mitochondrial Respiratory Capacity in Skeletal Muscle
Morris, J. K., McCoin, C. S., Fuller, K. N. Z., John, C. S., Wilkins, H., Green, Z. D., Wang, X., Sharma, P., Burns, J. M., Vidoni, E. D., et al. (2021) · Function · doi:10.1093/function/zqab045 · Cited by 26
Tran, D., Baxter, J., Hamman, R. F., & Grigsby, J. (2013) · Journal of Behavioral Medicine · doi:10.1007/s10865-013-9499-4 · Cited by 31
“For example, some reports have noted a link between diabetes and both vascular dementia and Alzheimer’s disease (AD; Bruce et al., 2001; Stewart & Liolitsa, 1999), possibly in conjunction with an increase in the prevalence of cerebrovascular disease (CVD) among diabetic persons.”
Lee, K. S., Jang, Y., Chung, Y. K., Chung, J. H., Oh, B. H., & Hong, C. H. (2009) · Archives of Gerontology and Geriatrics · doi:10.1016/j.archger.2009.01.014 · Cited by 27
“, 2005), diabetes (Elias et al., 1997; Stewart and Liolitsa, 1999), dyslipidemia (Isbir et al.”
Alzheimer’s Disease: Halothane Induces Aβ Peptide to Oligomeric Form—Solution NMR Studies
Mandal, P. K., Pettegrew, J. W., McKeag, D. W., & Mandal, R. (2006) · Neurochemical Research · doi:10.1007/s11064-006-9092-0 · Cited by 27
“These risk factors for AD are age [8], low educational attainment [9], gender (AD affects more women than men) [10], head injury [11], hypertension [12], cardiovascular disease [13] and diabetes [14].”
BackgroundRetractedMussell, M., Hewer, W., Kulzer, B., Bergis, K., & Rist, F. (2004) · Diabetic Medicine · doi:10.1111/j.1464-5491.2004.01322.x · Cited by 27
Vascular Risk Factors and Alzheimer's Disease
Stewart, R. J., Prince, M. J., & MANN, A. H. (1999) · Australian & New Zealand Journal of Psychiatry · doi:10.1046/j.1440-1614.1999.00657.x · Cited by 26
“Recent evidence has suggested potentially important similarities between the intracellular pathways of insulin metabolism and those involved in the phosphorylation of tau protein (underlying neurofibrillary tangle formation in AD), raising the possibility of common, possibly genetically determined, abnormalities under…”
BackgroundSelf-citationZheng, M., Zou, C., Li, M., Huang, G., Gao, Y., & Liu, H. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18040861 · Cited by 27
“A number of cross-sectional and longitudinal studies have examined the association between type II diabetes mellitus (DM) and cognitive impairment [4,5], mild cognitive impairment (MCI), and dementia [6].”
BackgroundAppropriate Application of Evidence to the Care of Elderly Patients with Diabetes
Huang, E. S. (2007) · Current Diabetes Reviews · doi:10.2174/1573399810703040260 · Cited by 26
“Other geriatric syndromes, such as depression [31], cognitive impairment [32], urinary incontinence [33], and chronic pain [34] are more common among elderly patients with diabetes and may be of great importance to the patient.”
BackgroundVascular and Endothelial Function in Youth with Type 2 Diabetes Mellitus
SHAH, A. S., & Urbina, E. M. (2017) · Current Diabetes Reports · doi:10.1007/s11892-017-0869-0 · Cited by 26
Cognitive Functioning and Self-Management in Older People With Diabetes
Asimakopoulou, K. G., & Hampson, S. E. (2002) · Diabetes Spectrum · doi:10.2337/diaspect.15.2.116 · Cited by 26
Chen, F., Ghosh, A., Hu, M. Y., Long, Y., Sun, H., Kong, L., Hong, H., & Tang, S. (2017) · Neurotoxicity Research · doi:10.1007/s12640-017-9784-z · Cited by 26
“A growing number of clinical and epidemiological evidences correlate a strong connection between type 2 diabetes (T2D) and Alzheimer’s disease (AD) (Arvanitakis et al. 2004; Sanz et al. 2012; Stewart and Liolitsa 1999).”
BackgroundHeat therapy: possible benefits for cognitive function and the aging brain
Schulze, A. T. V., Deng, F., Morris, J. K., & Geiger, P. C. (2020) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00168.2020 · Cited by 26
“Mitochondrial dysfunction in skeletal muscle has also been heavily studied as a primary cause of whole body insulin resistance (41, 72, 127), a recognized risk factor for AD (9, 24, 60, 74, 80, 93, 97, 100, 110, 119, 123, 124).”
BackgroundSinan, K. I., Zengin, G., Zheleva‐Dimitrova, D., Gevrenova, R., Picot-Allain, M. C. N., Dall’Acqua, S., Behl, T., Goh, B. H., Tang, S. Y., & Mahomoodally, M. F. (2021) · Antioxidants · doi:10.3390/antiox10111771 · Cited by 25
Fleshing out the amyloid cascade hypothesis: the molecular biology of Alzheimer's disease
Lovestone, S. (2000) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2000.2.2/slovestone · Cited by 28
“However, in cells, we demonstrated that it is only glycogen synthase kinase–3 (GSK-3) that is able to phosphorylate tau readily at epitopes also phosphorylated in AD.57,58 Simultaneously, Ishiguro and colleagues purified a kinase from brain that readily phosphorylated tau, which they named tau protein kinase 1 (TPK1).…”
BackgroundInfluentialNeuroanatomical correlates of executive functioning in depressed adults with type 2 diabetes
Watari, K. F., Elderkin‐Thompson, V., Ajilore, O., Haroon, E., Darwin, C. H., Pham, D. L., & Kumar, A. (2008) · Journal of Clinical and Experimental Neuropsychology · doi:10.1080/13803390701440486 · Cited by 25
“…Gagnon, & Messier, 2004), specifically in the domains of verbal memory, executive functioning and psychomotor speed; however, methodological and study design differences have resulted in tentative conclusions (Hassing et al., 2004; Stewart & Liolitsa, 1999; Strachan, Deary, Ewing, & Frier, 1997).”
ResultGlucose regulation is associated with cognitive performance in young nondiabetic adults
Messier, C., Awad, N., Gagnon, M., Desrochers, A., & Tsiakas, M. (2011) · Behavioural Brain Research · doi:10.1016/j.bbr.2011.03.023 · Cited by 25
Synaptic plasticity in the diabetic brain: advanced aging?
Artola, A., Kamal, A., Ramakers, G., Gardoni, F., di Luca, M., Biessels, G., Cattabeni, F., & Gispen, W. (2002) · Progress in Brain Research · doi:10.1016/s0079-6123(02)38084-1 · Cited by 28
Management of Diabetes Mellitus in Older Adults: Are National Guidelines Appropriate?
Blaum, C. S. (2002) · Journal of the American Geriatrics Society · doi:10.1046/j.1532-5415.2002.50130.x · Cited by 25
Effects of demographic variables and health status on brief vocabulary measures in Greek
Simos, P. G., Kasselimis, D. S., & Mouzaki, A. (2010) · Aphasiology · doi:10.1080/02687038.2010.512120 · Cited by 24
“Finally, the study did not provide detailed information on several important variables in participants who reported suffering from Type-II diabetes, namely the duration of the disease, degree of compliance with medication and diet regimes, overall success in controlling glucose levels, and presence of other vascular r…”
BackgroundIs There Inflammatory Synergy in Type II Diabetes Mellitus and Alzheimer’s Disease?
Lue, L., Andrade, C., Sabbagh, M. N., & Walker, D. G. (2012) · International Journal of Alzheimer s Disease · doi:10.1155/2012/918680 · Cited by 24
Gallacher, J., Pickering, J. E., Elwood, P. C., Bayer, A. J., YARNELL, J. W. G., & Ben‐Shlomo, Y. (2005) · European Journal of Epidemiology · doi:10.1007/s10654-005-2146-9 · Cited by 24
“Hyperglycemic related vascular and neurological complications of diabetes have led some to suggest that vascular and neurological pathology are the mechanism by diabetes is related to cognitive impairment [22, 23].”
BackgroundStewart, R. J., Kim, J., Shin, I., & Yoon, J. (2003) · International Psychogeriatrics · doi:10.1017/s1041610203008731 · Cited by 24
Self-citationClinical and Genetic Aspects of Epilepsy
Heron, S., & Mulley, J. (2011) · InTech eBooks · doi:10.5772/1138 · Cited by 24
Metadata
- Authors
- Stewart, R., & Liolitsa, D.
- Corresponding author
- Stewart, R.
- ORCID
- Stewart, R.
- Venue
- Diabetic Medicine
- Publisher
- Wiley
- Published
- 1999-02
- Volume
- 16
- Issue
- 2
- Pages
- 93-112
- ISSN
- 0742-3071 (ISSN-L)
- 1464-5491
- OpenAlex
- W2078868323
- Cited by
- 562
- References
- 145
- Citations by year
- 2026: 2 · 2025: 12 · 2024: 13 · 2023: 11 · 2022: 12 · 2021: 12 · 2020: 18 · 2019: 18 · 2018: 18 · 2017: 18 · 2016: 19 · 2015: 33 · 2014: 17 · 2013: 21 · 2012: 35
- FWCI
- 9.03
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Diabetic Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Wellcome Trust
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Life Sciences › Neuroscience › Neurology › Neurological Disease Mechanisms and Treatments
- Keywords
- type 2 diabetes, cognitive impairment, dementia, vascular dementia, Alzheimer's disease, memory, executive function, hypertension, dyslipidemia, apolipoprotein E, dementia classification
- MeSH terms
- Cognition Disorders, Cross-Sectional Studies, Dementia, Diabetes Mellitus, Type 2, Humans, Population Surveillance, Prospective Studies, Risk Factors, Case-Control Studies
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review